4
Changes in Ownership
Evofem Biosciences, Inc. Filed Acc 0001209191-15-065009
VP, Pharma Dev & Manufacturing sold 1,000 shares at $12.88 ($12,880)
- VP, Pharma Dev & Manufacturing acquired 1,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kemmerer Christopher VP, Pharma Dev & Manufacturing | 2015-08-07 | Option exercise | +1,000 | $1.22 | $1,220 | 11,848 | D |
| Kemmerer Christopher VP, Pharma Dev & Manufacturing | 2015-08-07 | Sale | −1,000 | $12.88 | $12,880 | 10,848 | D |
| Derivatives | |||||||
| Kemmerer Christopher VP, Pharma Dev & Manufacturing | 2015-08-07 | Option exercise · Stock Option (Right to Buy) | −1,000 | 1,710 | D | ||
| Open-market sales · 1,000 sh · avg $12.88 · $12,880 | |||||||
Loading xslF345X03/doc4.xml…